Ipsum Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Ipsum Pharmaceuticals Private Limited

Ipsum Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2012 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2012PTC082077. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.70 M.

It upholds a compliant status. Its leadership includes Palla Aparna (Director), Shyamala Budda (Director), Appala Shashikala (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 101 & 102A, Road No 4, Raghavendra Nagar Bandlaguda,Nagole, Hyderabad, Telangana, 500068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PTC082077

  • Registration Number

    082077

  • Incorporation Date

    20 July 2012

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹4.70 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 4.70 M
  • Company Age 13 Year, 7 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** 4.07%
  • Profit Growth **** 9.17%
  • Ebitda **** 1.42%
  • Net Worth 9.88%
  • Total Assets **** 36.78%
Company report

Ipsum Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ipsum Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ipsum Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Palla Aparna Director 20 Jul 2012 Current
Shyamala Budda Director 20 Jul 2012 Current
Appala Shashikala Director 20 Jul 2012 Current
Abhishek Budda Director 20 Jul 2012 Current
Narender Rao Kalakuntla Director 20 Jul 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ipsum Pharmaceuticals.

Ipsum Pharmaceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 4.07% increase. The company also saw a slight improvement in profitability, with a 9.17% increase in profit. The company's net worth moved up by a moderate rise of 9.88%.

Ipsum Pharmaceuticals revenue growth over time
Ipsum Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.07%
*******
*******
*******
*******
Revenue from Operations
*******
 4.07%
*******
*******
*******
*******
Total Assets
*******
 36.78%
*******
*******
*******
*******
Profit or Loss
*******
 9.17%
*******
*******
*******
*******
Net Worth
*******
 9.88%
*******
*******
*******
*******
EBITDA
*******
 1.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ipsum Pharmaceuticals?

In 2017, Ipsum Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ipsum Pharmaceuticals?

Unlock and access historical data on people associated with Ipsum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ipsum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipsum Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ipsum Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ipsum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.

  • Balance Sheet

    Ipsum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Palla Aparna was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Shyamala Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 7 months . was documented.

  • Director Appointment

    The activity Appala Shashikala was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 7 months . was completed.

  • Director Appointment

    Progress on Abhishek Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ipsum Pharmaceuticals Private Limited?

The CIN of Ipsum Pharmaceuticals Private Limited is U24232TG2012PTC082077.

Where is Ipsum Pharmaceuticals Private Limited headquartered?

Ipsum Pharmaceuticals Private Limited is headquartered at Plot No 101 & 102A, Road No 4, Raghavendra Nagar Bandlaguda,Nagole, Hyderabad, Telangana, 500068.

When was Ipsum Pharmaceuticals Private Limited incorporated?

Ipsum Pharmaceuticals Private Limited was incorporated on 20 July 2012.

Who are the current directors of Ipsum Pharmaceuticals Private Limited?

The current directors of Ipsum Pharmaceuticals Private Limited are

What is the primary industry of Ipsum Pharmaceuticals Private Limited?

The primary industry of Ipsum Pharmaceuticals Private Limited is Trade.

Is Ipsum Pharmaceuticals Private Limited a listed company?

Ipsum Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ipsum Pharmaceuticals Private Limited?

The authorized capital of Ipsum Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.70 M.

What is the compliance status of Ipsum Pharmaceuticals Private Limited?

The compliance status of Ipsum Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available